Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.
- DOI
- 10.1007/s10620-023-08252-1
- Published
- 2024 May
- Container
- Digestive diseases and sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10620-023-08252-1,
title = {Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.},
author = {Peyrin-Biroulet L and Bossuyt P and Bettenworth D and Loftus EV Jr and Anjie SI and D'Haens G and Saruta M and Arkkila P and Park H and Choi D and Kim DH and Reinisch W},
year = {2024},
journal = {Digestive diseases and sciences},
doi = {10.1007/s10620-023-08252-1},
url = {https://doi.org/10.1007/s10620-023-08252-1}
}RIS
TY - JOUR TI - Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis. AU - Peyrin-Biroulet L AU - Bossuyt P AU - Bettenworth D AU - Loftus EV Jr AU - Anjie SI AU - D'Haens G AU - Saruta M AU - Arkkila P AU - Park H AU - Choi D AU - Kim DH AU - Reinisch W PY - 2024 JO - Digestive diseases and sciences DO - 10.1007/s10620-023-08252-1 UR - https://doi.org/10.1007/s10620-023-08252-1 ER -
APA
L, P., P, B., D, B., Jr, L. E., SI, A., G, D., M, S., P, A., H, P., D, C., DH, K., & W, R. (2024). Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.. Digestive diseases and sciences. https://doi.org/10.1007/s10620-023-08252-1
Source records
- pubmed · retrieved 2026-09-26T08:13:08.553Z